6-APDB (also known as 6-(2-aminopropyl)-2,3-dihydrobenzofuran or 4-Desoxy-MDA) is a stimulant and entactogenic research chemical of the phenethylamine and benzofuran classes. It is a closely related synthetic analogue of MDA and 6-APB and broadly shares the characteristics of serotonin-selective triple monoamine releasers and reuptake inhibitors associated with other entactogenic or empathogenic compounds.
Because 6-APDB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity as a substitute or replacement for serotonergic entactogens like MDMA or MDA.
6-APDB acts as a releasing agent and triple reuptake inhibitor of the monoamine neurotransmitters known as serotonin,dopamine and noradrenaline which are the global neurotransmitters that modulate the brain’s ability to feel pleasure, motivation, reward, planning, attention and focus.
Spontaneous physical sensations – The “body high” of 6-APDB can be described as a moderate to extreme euphoric tingling sensation that radiates throughout the entire body.
Stimulation and Sedation – In terms of its effects on the user’s physical energy levels, 6-APDB is commonly considered to have the paradoxical ability to both be stimulating as well as sedating and relaxing. Overall, it is thought to be far less energetic than MDMA or MDA.
Bodily control enhancement
Increased blood pressure
Increased bodily temperature
Increased heart rate
Perception of bodily lightness
Teeth grinding – This is usually only present at moderate to higher doses and is similar to what one might experience from MDMA or MDA.
Temporary erectile dysfunction
6-APDB is sold for research purposes only and is not be utilized for any other purposes.